Treatment INDs
Executive Summary
FDA Commissioner Young predicted approvals of 10-20 Treatment INDs during the next two years as a result of increased AIDS R&D activity. His forecast is based on the upsurge of IND filings for drugs to treat AIDS and AIDS-related illnesses. AIDS IND submissions are averaging 10 per month this year, compared with five per month in 1987 and 2.5 per month in 1986.